Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury

Completed · Not applicable · Has a placebo group

Conditions studied: Spinal Cord Injury

In brief

This study was initially designed to test the efficacy of Venlafaxine HCl in reducing incidence of the onset of major depression after a new spinal cord injury (SCI). After several protocol modifications, the purpose of the study is to test the effectiveness of a sub-therapeutic dose of Venlafaxine HCl to reduce mild to moderate symptoms in persons with SCI.

Key facts

Study ID
NCT00735670
Run by
University of Michigan
People needed
34
Starts
2008-06-01
Expected to finish
2012-08-01
Last updated by the study team
2016-10-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.